NCT06208137招募中不适用
Using the Composite Immune Risk Score to Assess and Modulate the Patient's Immune Reconstitution After Allogeneic Hematopoietic Stem Cell Transplantation, a Prospective, Multicenter, Randomized Controlled Study.
Institute of Hematology & Blood Diseases Hospital, China1 个研究点 分布在 1 个国家目标入组 456 人开始时间: 2024年2月29日最近更新:
适应症
试验速览
- 阶段
- 不适用
- 状态
- 招募中
- 入组人数
- 456
- 试验地点
- 1
- 主要终点
- Survival
研究概览
简要总结
To assess the effectiveness of interventions including health monitoring and regular return follow-up reminders for patients with a high Composite Immune Risk Score.
详细描述
This study aims to prospectively evaluate the effectiveness of the Composite Immune Risk Score in real-world clinical setting.
研究设计
- 研究类型
- Interventional
- 分配方式
- Randomized
- 干预模型
- Parallel
- 主要目的
- Supportive Care
- 盲法
- None
入排标准
- 年龄范围
- 16 Years 至 —（Child, Adult, Older Adult）
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- •Patients must be ≥ 16 years of age;
- •Patients receiving haploidentical allo-HSCT;
- •Patients have to sign an informed consent form before the start of the research procedure.
排除标准
- •Tandem transplantation or multiple transplantations;
- •Mental or other medical conditions that make the patients unable to comply with the research treatment and monitoring requirements;
- •Patients who are ineligible for the study due to other factors, or will bear great risk if participating in the study.
结局指标
主要结局
Survival
时间窗: 1.5 years after transplantation
Overall survival during 1.5 years after transplantation
次要结局
- Non-relapse mortality rate(1.5 years after transplantation)
- Incidence of infections(1.5 years after transplantation)
- Immune cell count(1.5 years after transplantation)
研究者
研究点 (1)
Loading locations...
相似试验
招募中
不适用
Immunity Markers in Intensive Care Patients and Ventilator-associated PneumoniaPneumonia, Ventilator-AssociatedNCT06607055Centre Hospitalier Intercommunal Aix-Pertuis40
招募中
不适用
First-Line and Neoadjuvant Immunotherapy for Gastric CancerAdvanced Gastric CancerLocally Advanced Gastric CarcinomaNCT06727981Qilu Hospital of Shandong University500
尚未招募
3 期
Immunoscore as Decision Guidance for Adjuvant Chemotherapy in Colon CancerColon Cancer Stage IIINCT04488159Johannes Laengle, MD, PhD1,638
招募中
不适用
Evaluating and Monitoring Immune and Clinical Responses in Early-Stage Triple Negative Breast Cancer Undergoing Neoadjuvant Chemo-immunotherapy With PembrolizumabBreast Cancer Triple NegativeBreast Cancer Stage IIBreast Cancer Stage IIIBreast Cancer InvasiveNCT05877859Emory University10
已完成
不适用
iPeer2Peer Pediatric Thoracic TransplantationSolid Organ TransplantNCT04253548The Hospital for Sick Children34